SEC Form 4/A · accession 0001562180-17-001485
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Andrew R Robbins
Officer — COO
Period of report
Apr 1, 2017
Accepted (ET)
Apr 6, 2017 · 8:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2017 | F | 9,167 | $8.94 | D | 36,684 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment to form 4 is being filed to correct number of shares withheld to satisfy the reporting person's tax withholding obligations in connection with the vesting of Restricted Stock Units previously reported on a form 4 by the reporting person. No other information in such form 4 is being amended.